Close Menu

This article has been updated with comments from Wells Fargo and corrected to acurately reflect the expected Q4 and FY 2015 EPS figures.

NEW YORK (GenomeWeb) – Qiagen today reported preliminary earnings for the fourth quarter and fiscal year 2015 that fell short of management's outlook and analyst expectations. The firm also reported a previously undisclosed acquisition of sample prep firm Mo Bio Laboratories.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Retraction Watch writes that a cancer researcher has had an eighth paper retracted.

Computational biologist James Taylor has died, according to Johns Hopkins University.

The Centers for Disease Control and Prevention is starting to test people for SARS-CoV-2 antibodies, according to the New York Times.

In PLOS this week: features of tumor-infiltrating immune cells, regulatory effects of SNPs associated with prostate cancer risk, and more.